Epoch 34: Chasing Blockbusters - High-Stakes Approvals Define 1H 2024
Macro, New Approvals, BioSecure Act
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For the week XBI was UP +2.5% and remains green at +12% for the year. To start, we have some insightful market data to share. The old adage says, "Sell in May and Go Away," but after reviewing this data, we migh…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.